UCSF’s innovative, collaborative approach to patient care, research and education spans disciplines across the life sciences, making it a world leader in scientific discovery and its translation to improving health.
Shreya Hegde is an alumnus of the University of Texas at Austin and has a strong passion for neuroscience and research. She helps coordinate the Frontotemporal Dementia: Genes, Images and Emotions program project.
Cesar holds bachelor’s degrees in psychology and ecology from the University of California, Davis and a Master of Public Health in epidemiology from Boston University. Prior to joining the UCSF Memory and Aging Center, Cesar worked in the Women’s Health Clinical Research Center (WHCRC) at UCSF managing data for the San Francisco Mammography Registry (SFMR) database and various clinical trial studies.
Joe Hesse joined the Memory and Aging Center in 2002 and serves as the center’s Director of Innovation. His focus is the development of informatics and computational infrastructure in support of precision medicine. He works in collaboration with many groups and faculty across UCSF with the overall goal of delivering technology solutions to clinicians and researchers that are both scientifically agile and regulatory compliant.
Dr. Margo Heston is a postdoctoral scholar and an NIH F99/K00 fellow funded through the NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) program.
Tanisha Hill-Jarrett, PhD, is a neuropsychologist and an assistant professor of neurology at the UCSF Memory and Aging Center. Her research applies intersectionality theory to understand how psychosocial stressors and structural racism and sexism impact Black women’s cognitive aging and confer risk for Alzheimer’s disease and related dementias (ADRD).
Molly studied Neuroscience and Psychology at the University of California, Los Angeles. She then completed her PhD degree with Professor Peter Juo at Tufts University, where she investigated the regulation of the AMPA-type glutamate receptor by its deubiquitinating enzyme USP-46 in C. elegans. She identified two novel mechanisms by which USP-46 is stabilized and activated by two WD40-repeat proteins, WDR-48 and WDR-20, to promote AMPAR abundance and recycling to the neuronal surface. In the Kao lab, Molly will continue her research in protein homeostasis and degradation in C.
Brandon Holmes, MD, PhD, is an Assistant Professor at the Memory and Aging Center (MAC). He completed his clinical fellowship at the MAC and his post-doctoral research in the Department of Pharmaceutical Chemistry in the laboratory of James A. Wells, PhD, where he studies how microglia, the innate immune cells of the central nervous system, alter their proteome in the context of neurodegeneration and neuroinflammation. Learn more about his research here.
Dr. Kiet (Robert) Hua completed a Bachelor of Science degree in Neurobiology, Physiology and Behavior at the University of California, Davis. During his undergraduate studies, he developed a love of research, studying animal behavior. He completed further research training at the University of Houston where he studied drosophila genetics. He completed his Medical Degree (MD) and Doctor of Philosophy (PhD) degrees at Albany Medical College. His PhD thesis focused on the study of primary cilia and their role in a category of neurodevelopmental disorders known as ciliopathies.
Maria joined the Memory and Aging Center in February 2021 as Administrative Manager to provide operational, analytical and administrative support to the Neurodegenerative Disease Brain Bank. She has a BA degree in education, with minors in mathematics and Spanish literature from the University of Pennsylvania. Before joining the MAC, Maria managed education programs, business solutions and strategic initiatives in the healthcare, insurance and financial services industries, both nationally and internationally.
San-Hae is a postdoctoral researcher at the UCSF Memory and Aging Center under the mentorship of Dr. Claire Clelland. His research focuses on developing delivery systems for CRISPR-based therapies to treat neurodegenerative diseases.
